| Expression pattern: |
UP |
| Associated gene: |
SOX4 |
| Associated microRNA: |
miR-330-5p |
| Biological function: |
circRNF220 promotes AML cell proliferation, cell cycle progression, invasion, and glycolytic metabolism, and inhibits apoptosis. |
| Molecular mechanism: |
circRNF220 acts as a sponge for miR-330-5p to up-regulate SOX4 expression via a circRNF220/miR-330-5p/SOX4 ceRNA axis. |
| Biological pathway or process: |
proliferation (promotes); cell cycle (promotes); apoptosis (inhibits); invasion (promotes); glycolysis (promotes); ceRNA regulation (promotes) |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RT-qPCR; Clinical Sample Validation; Actinomycin D / DRB Stability Assay; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; Transfection; MTT; EdU Staining; Cell Cycle Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Luciferase Reporter Assay; RNA Pull-Down; Western Blot; Bioinformatics Analysis |
| Clinical significance: |
circRNF220 expression was analyzed in relation to clinicopathological parameters of AML patients, but no clear diagnostic or prognostic conclusion for circRNF220 was reported. |
| Description: |
circRNF220 is up-regulated in AML serum samples and AML cell lines. It promotes AML cell proliferation, cell cycle progression, invasion, and glycolysis while suppressing apoptosis, mainly through sponging miR-330-5p to increase SOX4 expression. |
| Confidence score: |
0.8206 |